SHZ:300030

Improve Medical Instruments Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:24 UTC

Last close

n/aCNY

Market data

138.3xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
2.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
3.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
17.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.23Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.3%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

Price is the furthest below its sector's middle: 0.18 against 0.36 on the market's range.

All from 100

lens 2 of 9

Sales

94.0

2016-12-31 to 2025-12-31100 at the start94.0

Sales: 100.00 on 2016-12-31 to 94.04 on 2025-12-31, down 6%.

Profit

47.7

2016-12-31 to 2025-12-31100 at the start47.7

Profit: 100.00 on 2016-12-31 to 47.68 on 2025-12-31, down 52%.

Shares in issue

95.5

2016-12-31 to 2025-12-31100 at the start95.5

Shares in issue: 100.00 on 2016-12-31 to 95.48 on 2025-12-31, down 5%.

Sales is at 94, Profit is at 48, Shares in issue is at 96, against 100 in 2016.

Sales is at 94, Profit is at 48, Shares in issue is at 96, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 10094
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 10048
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 10096
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY